| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.47B | — | +15.7% |
| Cost of Revenue | $638.0M | — | +15.1% |
| Gross Profit | $1.84B | — | +15.9% |
| R&D Expense | $528.0M | — | +9.9% |
| SG&A Expense | $179.0M | — | +83.2% |
| Operating Income | $309.0M | — | +7.9% |
| Pre-tax Income | $412.0M | — |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.07B | +35.1% | +34.3% |
| Short-term Investments | $1.14B | +80.3% | +3.2% |
| Accounts Receivable | $1.34B | -54.7% | +18.5% |
| Current Assets | $7.31B | -2.8% | +17.1% |
| Total Assets | $23.54B | -0.2% | +15.5% |
| Current Liabilities |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.77B | — | +17.3% |
| Investing Cash Flow | -$983.0M | — | -80.8% |
| Financing Cash Flow | $8.0M | — | +103.6% |
| +11.8% |
| Income Tax | $78.0M | — | +335.8% |
| Net Income | $334.0M | — | -4.8% |
| EPS (Basic) | $0.49 | — | -54.2% |
| EPS (Diluted) | $0.47 | — | -52.5% |
| $7.42B |
| -7.1% |
| +0.2% |
| Total Liabilities | $14.87B | -5.6% | +2.8% |
| Stockholders' Equity | $8.66B | +10.7% | +46.6% |